Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide
LGALS9
适用: 人
宿主: 合成
BP, WB
Quick Overview for Lectin, Galactoside-Binding, Soluble, 9 (LGALS9) (Middle Region) Peptide (ABIN5512361)
抗原
Galectin 9 (LGALS9)
(Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
-
-
蛋白结构域
- Middle Region
-
序列
- YVVCNTRQNG SWGPEERKTH MPFQKGMPFD LCFLVQSSDF KVMVNGILFV
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-LGALS9 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Galectin 9 (LGALS9) (Lectin, Galactoside-Binding, Soluble, 9 (LGALS9))
-
背景
-
The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.
Protein Size: 323 -
基因ID
- 3965
抗原
-
You are here:
